Amplifon S.p.A Operating Expenses 2019-2025 | AMFPF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Amplifon S.p.A operating expenses from 2019 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Amplifon S.p.A operating expenses from 2019 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$151.4B
CVS Health (CVS)	$89.8B
Elevance Health (ELV)	$69.8B
Cencora (COR)	$58.9B
DiDi Global (DIDIY)	$28.4B
Labcorp Holdings (LH)	$23.1B
Natera (NTRA)	$22B
BioMerieux (BMXMF)	$17.6B
EUROFINS SCIENT (ERFSF)	$15.7B
ICON (ICLR)	$14.6B
Medpace Holdings (MEDP)	$13.1B
Solventum (SOLV)	$12.6B
CochLear (CHEOY)	$12.5B
Viatris (VTRS)	$12.4B
Revvity (RVTY)	$10.6B
Caris Life Sciences,�Inc (CAI)	$9.9B
Sonic Healthcare (SKHHY)	$9.2B
Avantor (AVTR)	$8.8B
Charles River Laboratories (CRL)	$7.9B
HealthEquity (HQY)	$7.7B
Bausch + Lomb (BLCO)	$5.1B
Sotera Health (SHC)	$4.6B
BrightSpring Health Services (BTSG)	$4.2B
GeneDx Holdings (WGS)	$3.5B
Surgery Partners (SGRY)	$3.1B
Alignment Healthcare (ALHC)	$3B
Concentras Parent (CON)	$3B
Organon (OGN)	$2.4B
Premier (PINC)	$2.1B
Progyny (PGNY)	$1.9B